Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 163
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 69
Immune Disorders Drugs 61
Pharmaceuticals 50
Drug Discovery 48
Cardiovascular Drugs 46
Biopharmaceuticals 43
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Clinical Trials 31
Lymphoma Drugs 30
Allergy and Immunology 28
Musculoskeletal Disorders Drugs 28
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,028 Results (Page 37 of 52)
- Relevance
  Sort by

Direct Acting Antivirals Market - Global Forecast 2026-2032

 Report
January 2026
180 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Anti-Rheumatics Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Collagen Vascular Diseases Market - Global Forecast 2026-2032

 Report
January 2026
191 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027

 Report
January 2022
292 Pages
Global

From

€3274EUR$3,750USD£2,835GBP

Conjunctivitis Treatment Market Size, Share & Trends Analysis Report By Disease Type, By Drug Class (Anti-allergic, Antiviral, Artificial Tears, and Antibiotics), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

 Report
February 2024
232 Pages
Global

From

€3143EUR$3,600USD£2,721GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Nucleic Acid-Based Drugs Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Antibody Drug Conjugates Market 2025-2029

 Report
January 2025
189 Pages
Global

From

€2183EUR$2,500USD£1,890GBP

Nanomedicine Market Report and Forecast 2023-2031

 Report
May 2023
147 Pages
Global

From

€4321EUR$4,949USD£3,741GBP

Polycythemia Vera Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4339EUR$4,969USD£3,756GBP

Cytomegalovirus Treatment Drugs Market - Global Forecast 2025-2030

 Report
August 2025
191 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Orphan Drugs Market 2024-2028

 Report
August 2024
180 Pages
Global

From

€2183EUR$2,500USD£1,890GBP

Specialty Pharmaceuticals Market - Global Forecast 2026-2032

 Report
January 2026
190 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Nanomaterials in Personalized Medicine: Global Markets

 Report
October 2023
226 Pages
Global

From

€4060EUR$4,650USD£3,515GBP

Pharmaceutical Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
January 2026
284 Pages
Global

From

€4147EUR$4,750USD£3,591GBP

Herpangina Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

 Report
January 2026
185 Pages
Global

From

€3929EUR$4,500USD£3,402GBP

Hypertrophic Cardiomyopathy Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3920EUR$4,490USD£3,394GBP

Filgotinib Tablets Market - Global Forecast 2026-2032

 Report
January 2026
182 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Oral JAK Inhibitors Market - Global Forecast 2026-2032

 Report
January 2026
184 Pages
Global

From

€3439EUR$3,939USD£2,978GBP

Congenital Heart Disease - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1746EUR$2,000USD£1,512GBP

Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
November 2025
185 Pages
Global

From

€3929EUR$4,500USD£3,402GBP

1,028 Results (Page 37 of 52)
- 1
- 35
- 36
- 37
- 38
- 39

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.